North Charleston, South Carolina - September 28, 2005 - Argolyn Bioscience announced today that it has been selected by Southeast BIO (SEBIO) to present at its Seventh Annual Southeast BIO Investor Forum.

The SEBIO Investor Forum, which will take place November 30th - December 2nd, 2005, at the Charleston Place Hotel in Charleston, South Carolina, is the Southeast's premier life sciences venture capital conference. Argolyn Bioscience will be presenting on December 2.

The event will explore research, market, and financing trends with nationally recognized leaders from the investment and biosciences industries. Participants will include biotechnology executives, entrepreneurs, venture capitalists, investment bankers, and other industry professionals.

About Argolyn Bioscience Inc.

Argolyn Bioscience Inc. is a peptide product development company headquartered in North Charleston, South Carolina. Argolyn is the exclusive worldwide licensee for a portfolio of patents and patent applications aimed at improving the pharmacology of peptide drug candidates. The company has one product in preclinical development and several other discovery stage product programs. Argolyn Bioscience continues to seek other opportunities to disseminate the technology either through collaboration or out-licensing. For more information, contact the company or visit the website at www.argolyn.com.

About Southeast BIO

Southeast BIO (SEBIO) is a regional nonprofit organization that fosters the growth of the life sciences industry in the Southeastern U.S. through efforts that promote entrepreneurship and bring together companies, investors, universities, and support organizations active in the development of the industry. Today, the Southeast is recognized as one of the fastest growing life sciences regions in the U.S. and home to more than 220 life sciences companies. A public/private partnership formed in 1999, SEBIO is committed to conducting activities that create regional leverage and facilitate the common interests and goals of constituents in the life sciences industry. The geographic footprint of SEBIO presently includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia. For more information on SEBIO, go to www.sebio.org.

For More Information, Contact:
Pearce Gilbert
Argolyn Bioscience Inc.
Tel: (843) 266-0851
Fax: (843) 266-0894
info@argolyn.com